BIOMAT Database Logo BIOMAT Database Logo

Synthesis and Antibacterial Activity Evaluation of Imidazole Derivatives Containing 6-Methylpyridine Moiety. 2023

Wen-Bo Xu, and Yu-Qing Meng, and Jingxin Sun, and Yu-Xuan Yang, and Wan-Xin Li, and Man-Yu Wang, and Ming-Guan Piao, and Siqi Li, and Jishan Quan, and Cheng-Hua Jin
Interdisciplinary Program of Biological Function Molecules, College of Integration Science, Yanbian University, Yanji, 133002, China.

A series of 2-cyclopropyl-5-(5-(6-methylpyridin-2-yl)-2-substituted-1H-imidazol-4-yl)-6-phenylimidazo[2,1-b][1,3,4]thiadiazoles (15a-t and 16a-f) were synthesized and their antibacterial activities were evaluated. More than half of the compounds showed moderate or strong antibacterial activity. Among them, compounds 15t (MIC=1-2 μg/mL) and 16d (MIC=0.5 μg/mL) showed the strongest antibacterial activities. Notably, compound 16d did not exhibit cytotoxicity in HepG2 cells and did not show hemolysis like the positive control compound Gatifloxacin. The results suggest that compound 16d should be further investigated as a candidate antibacterial agent.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009593 Nitroimidazoles IMIDAZOLES having a nitro moiety. Nitroimidazole
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Wen-Bo Xu, and Yu-Qing Meng, and Jingxin Sun, and Yu-Xuan Yang, and Wan-Xin Li, and Man-Yu Wang, and Ming-Guan Piao, and Siqi Li, and Jishan Quan, and Cheng-Hua Jin
Synthesis of amide derivatives containing the imidazole moiety and evaluation of their anti-cardiac fibrosis activity.
April 2024, Archiv der Pharmazie,
Wen-Bo Xu, and Yu-Qing Meng, and Jingxin Sun, and Yu-Xuan Yang, and Wan-Xin Li, and Man-Yu Wang, and Ming-Guan Piao, and Siqi Li, and Jishan Quan, and Cheng-Hua Jin
Synthesis and antibacterial activity of novel curcumin derivatives containing heterocyclic moiety.
January 2013, Iranian journal of pharmaceutical research : IJPR,
Wen-Bo Xu, and Yu-Qing Meng, and Jingxin Sun, and Yu-Xuan Yang, and Wan-Xin Li, and Man-Yu Wang, and Ming-Guan Piao, and Siqi Li, and Jishan Quan, and Cheng-Hua Jin
Synthesis and antibacterial evaluation of novel oxazolidinone derivatives containing a piperidinyl moiety.
December 2019, Bioorganic & medicinal chemistry letters,
Wen-Bo Xu, and Yu-Qing Meng, and Jingxin Sun, and Yu-Xuan Yang, and Wan-Xin Li, and Man-Yu Wang, and Ming-Guan Piao, and Siqi Li, and Jishan Quan, and Cheng-Hua Jin
Synthesis, Biological Activity Evaluation and Molecular Docking of Imidazole Derivatives Possessing Hydrazone Moiety.
June 2023, Chemistry & biodiversity,
Wen-Bo Xu, and Yu-Qing Meng, and Jingxin Sun, and Yu-Xuan Yang, and Wan-Xin Li, and Man-Yu Wang, and Ming-Guan Piao, and Siqi Li, and Jishan Quan, and Cheng-Hua Jin
Synthesis and Antibacterial Evaluation of Novel 1,3,4-Oxadiazole Derivatives Containing Sulfonate/Carboxylate Moiety.
March 2020, Molecules (Basel, Switzerland),
Wen-Bo Xu, and Yu-Qing Meng, and Jingxin Sun, and Yu-Xuan Yang, and Wan-Xin Li, and Man-Yu Wang, and Ming-Guan Piao, and Siqi Li, and Jishan Quan, and Cheng-Hua Jin
Synthesis, antibacterial activity and mechanism of new butenolides derivatives containing an amide moiety.
October 2021, Pesticide biochemistry and physiology,
Wen-Bo Xu, and Yu-Qing Meng, and Jingxin Sun, and Yu-Xuan Yang, and Wan-Xin Li, and Man-Yu Wang, and Ming-Guan Piao, and Siqi Li, and Jishan Quan, and Cheng-Hua Jin
Synthesis and antibacterial activity of novel levofloxacin derivatives containing a substituted thienylethyl moiety.
August 2012, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences,
Wen-Bo Xu, and Yu-Qing Meng, and Jingxin Sun, and Yu-Xuan Yang, and Wan-Xin Li, and Man-Yu Wang, and Ming-Guan Piao, and Siqi Li, and Jishan Quan, and Cheng-Hua Jin
Synthesis and Evaluation of Imidazole Derivatives Bearing Imidazo[2,1-b] [1,3,4]thiadiazole Moiety as Antibacterial Agents.
January 2024, Medicinal chemistry (Shariqah (United Arab Emirates)),
Wen-Bo Xu, and Yu-Qing Meng, and Jingxin Sun, and Yu-Xuan Yang, and Wan-Xin Li, and Man-Yu Wang, and Ming-Guan Piao, and Siqi Li, and Jishan Quan, and Cheng-Hua Jin
Synthesis, antifungal and antibacterial activity for novel amide derivatives containing a triazole moiety.
February 2013, Chemistry Central journal,
Wen-Bo Xu, and Yu-Qing Meng, and Jingxin Sun, and Yu-Xuan Yang, and Wan-Xin Li, and Man-Yu Wang, and Ming-Guan Piao, and Siqi Li, and Jishan Quan, and Cheng-Hua Jin
Design, Synthesis, Antibacterial Activity, Antiviral Activity, and Mechanism of Myricetin Derivatives Containing a Quinazolinone Moiety.
November 2021, ACS omega,
Copied contents to your clipboard!